REGENXBIO Inc. (RGNX) Short Interest
Nasdaq • RGNX • US75901B1070
As of Oct 28, 2026, ORTEX estimated 17.7% of free float sold short, 7.2 days to cover, cost to borrow 0.46%. Sign up for live short interest data.
Nasdaq • RGNX • US75901B1070
As of Oct 28, 2026, ORTEX estimated 17.7% of free float sold short, 7.2 days to cover, cost to borrow 0.46%. Sign up for live short interest data.
This page tracks how heavily REGENXBIO Inc. (Nasdaq:RGNX) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
REGENXBIO Inc. (Nasdaq: RGNX) has a market capitalization of $560.06M. Last close $8.47 (as of 2026-11-12); 52-week range $5.46 to $16.19. ORTEX data as of 2026-10-28: short interest was 17.71% of free float, 7.2 days to cover and the average cost to borrow was 0.46%. Sign up for live short interest data.